Treatment-free remission after two nilotinib consolidation durations in chronic myeloid leukemia treated with imatinib: Phase 3 ENESTPath results

Réa D et al. Leukemia, January 2026 (epub ahead of print)

• Share
• Tweet
• Share
• Share